Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RSV604 in healthy adults experimentally infected with RSV
2008-000790-38Phase 2Completed
- Sponsor
- Novartis
- Start
- Jul 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in respiratory syncytial virus disease (RSV) comparing RSV604 arm with Placebo arm (2 arms). Primary endpoint: Nasally measured RSV viral load by RT-PCR. Started Jul 2008; status: completed.
02
Drugs
RSV-604
03
Conditions
respiratory syncytial virus disease (RSV)
Beyond the preview
Go deeper on 2008-000790-38.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000790-38.